Cargando…
Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells “LAG-3-ing” Behind
Preventing activation of diabetogenic T cells is critical for delaying type 1 diabetes onset. The inhibitory molecule lymphocyte activation gene 3 (LAG-3) and metalloprotease tumor necrosis factor-α converting enzyme (TACE) work together to regulate TH1 responses. The aim of this study was to determ...
Autores principales: | Delmastro, Meghan M., Styche, Alexis J., Trucco, Massimo M., Workman, Creg J., Vignali, Dario A.A., Piganelli, Jon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379669/ https://www.ncbi.nlm.nih.gov/pubmed/22586584 http://dx.doi.org/10.2337/db11-1591 |
Ejemplares similares
-
Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
por: Turnis, Meghan E., et al.
Publicado: (2012) -
Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 Diabetes
por: Padgett, Lindsey E., et al.
Publicado: (2015) -
The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
por: Andrews, Lawrence P, et al.
Publicado: (2015) -
In Vivo Enrichment of Diabetogenic T Cells
por: Thelin, Martin A., et al.
Publicado: (2017) -
Redox Modulation Protects Islets From Transplant-Related Injury
por: Sklavos, Martha M., et al.
Publicado: (2010)